Germany· DE-A57-616079f29509a25f
Ofloxacin Devatis
A ofloxacin product containing ofloxacin, registered in Germany by Devatis Gmbh. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC S01AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ofloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ofloxacin · price per daily dose (0.4 mg)
USD · FX 28 Sept 2026
- FR France$0.0016
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ofloxacin
- Manufacturer
- Devatis Gmbh
- Country
- Germany (DE)
- ATC code
- S01AE01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 mg, AT
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOCUFLOXAllergan, Inc.
- United KingdomExocin 0.3% eye dropsLexon (UK) Ltd
- PolandFloxalPretium Farm Sp. z o.o.
- FranceEXOCINE 0,3 POUR CENT, collyreABBVIE
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- NetherlandsOfloxacine 200 PCH, filmomhulde tabletten 200 mgPharmachemie B.V.
- Japanオフロキサシン沢井製薬
- SpainEXOCIN 3 MG/ML COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7d27697-599b-4fd2-b0b9-3962057fdc78 GET /v1/drugs/d7d27697-599b-4fd2-b0b9-3962057fdc78?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intraocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ofloxacin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.